Potent, stable antibodies to block SARS-CoV-2, variants developed
Berlin, July 29
Researchers have developed highly potent and stable antibodies from the blood of alpacas which can efficiently block SARS-CoV-2, the virus that causes Covid-19, and its dangerous new variants.
The researchers from the Max Planck Institute (MPI) for Biophysical Chemistry in Germany noted that these mini-antibodies bind and neutralise the virus up to 1,000 times better than previously developed such antibodies.
In the study published in The EMBO Journal, the researchers optimised the so called nanobodies for stability and resistance to extreme heat.
This unique combination makes them promise agents to treat Covid-19, they said.
Since nanobodies can be produced at low costs in large quantities, they could meet the global demand for Covid-19 therapeutics.
The researchers...